Table 1.

Baseline Values for Study Variables: a Factor of Sample Attrition.

	Baseline (n=80)	6 Months (n=51)	12 Months (n=44)
Age	68.20 ± 9.29	67.00 ± 8.77	66.55 ± 9.45
% Male	58.75	56.80	56.80
H&Y (Stage(n))	I(4), II(27), II.5(30), III(13), IV(6)	I(4), II(22), II.5(17), III(5), IV(3)	I(4), II(22), II.5(11), III(5), IV(2)
MDS-UPDRS III	41.34 ± 14.68	38.55 ± 13.13	37.52 ± 12.81
BESTest (%)	70.31 ± 16.74	72.93 ± 16.05	75.76 ± 12.99
Mini-BESTest	17.81 ± 6.01	18.61 ± 5.74	19.73 ± 5.00
BBS	47.89 ± 8.13	49.08 ± 8.23	50.07 ± 6.30
Freezer status (% sample)	40.00	39.20	29.50
PASE	123.34 ± 95.47	129.50 ± 86.14	137.90 ± 112.76
Fallers (% sample)	31.25	27.50	20.50
Levodopa Equivalent Daily Dose (LEDD)	855.22 ± 573.59	888.33 ± 648.72	870.57 ± 683.43

All values are mean ± SD unless otherwise indicated. All values represent baseline values for the sample at each time point.